Pharmacokinetics of the Intralesional administration with two doses of rhEGF (75 microg and 225 microg) in patients with advance Diabetic Foot Ulcers
Latest Information Update: 14 Oct 2020
At a glance
- Drugs Recombinant epidermal growth factor (Primary)
- Indications Diabetic foot ulcer
- Focus Pharmacokinetics
- 18 Mar 2013 New trial record